Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Insulinoma

Insulinoma

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Insulinoma

3 trials tracked for Insulinoma.

3Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 3
  1. Phase 2 Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Completed
  2. Phase 2 Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors Completed
  3. Phase 2 Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Surgical resolution of insulinoma may not fully reverse chronic hypoglycemia-induced peripheral neuropathy
Diabetes & Endocrinology Sys. Review
Surgical resolution of insulinoma may not fully reverse chronic hypoglycemia-induced peripheral neuropathy Surgery Can Help Reverse Nerve Damage From Low Blood Sugar
This case report and literature review describes a patient with a solitary pancreatic insulinoma and associated hypoglycemic polyneuropathy.…
A case study shows that surgery to remove a pancreatic tumor can resolve low blood sugar and improve some nerve damage.
Frontiers Aug 28, 2026
MDT management of insulinoma in pregnancy yields partial glycaemic control but fetal growth restriction occurred in this case
Diabetes & Endocrinology Sys. Review
MDT management of insulinoma in pregnancy yields partial glycaemic control but fetal growth restriction occurred in this case Multidisciplinary care manages insulinoma in pregnancy with mixed fetal outcomes
This literature review presents a case report of a 36-year-old gravida 4 para 2 woman with insulinoma during pregnancy. The multidisciplinar…
A single case report shows partial blood sugar control with octreotide and fetal growth restriction after EUS-RFA for an insulinoma during p…
Frontiers Jun 4, 2026